This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial - Abstract November 30, 2011
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes - Abstract November 30, 2011
Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer - Abstract November 30, 2011
Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease - Abstract November 30, 2011
Significance of serum total prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer - Abstract November 30, 2011
The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: A review of the literature - Abstract November 30, 2011
Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland - Abstract November 30, 2011
Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: A database study - Abstract November 30, 2011
Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy - Abstract November 30, 2011
Nuclear magnetic resonance-based metabolomics enables detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patients - Abstract November 29, 2011
Risk of prostate cancer associated with benign prostate disease: A primary care case-control study - Abstract November 29, 2011
Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia - Abstract November 29, 2011
Salvage therapy with oral metronomic cyclophosphamide and methotrexate for castration-refractory metastatic adenocarcinoma of the prostate resistant to docetaxel - Abstract November 29, 2011
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel - Abstract November 29, 2011
Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: Its importance for the sentinel node procedure - Abstract November 29, 2011
Prostate sampling by 12-core biopsy: Comparison of the biopsy results with tumor location in prostatectomy specimens - Abstract November 29, 2011
Clinical outcomes of intracavernosal injection in postprostatectomy patients: A single-center experience - Abstract November 29, 2011
Diffusion-weighted imaging in the prostate: An apparent diffusion coefficient comparison of half-Fourier acquisition single-shot turbo spin-echo and echo planar imaging - Abstract November 29, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy - Abstract November 29, 2011
Focal therapy for clinically localized prostate cancer - Abstract November 28, 2011
Page 1351 of 1451
  • Start
  • Prev
  • 1346
  • 1347
  • 1348
  • 1349
  • 1350
  • 1351
  • 1352
  • 1353
  • 1354
  • 1355
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free